{"id":"W1927694459","doi":"10.1183/13993003/erj.38.suppl_55.p876","title":"ACCORD COPD I: Twice-daily aclidinium bromide improves quality of life and dyspnea in COPD patients","year":2011,"lang":"en","type":"article","venue":"European Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Muscarinic antagonist; Placebo; Quality of life (healthcare); Anesthesia; Bronchodilator; Internal medicine; Physical therapy; Antagonist; Asthma; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001431649,0.0007626485,0.001654278,0.0002587938,0.0002477213,0.0005376803,0.0005008453,0.00083463,0.005631053],"category_scores_gemma":[0.0008279924,0.0002552485,0.000851846,0.0002195436,0.0002975868,0.0003392813,0.0003442949,0.001117695,0.0008146337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002292307,"about_ca_system_score_gemma":0.000561785,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004633507,"about_ca_topic_score_gemma":0.001094791,"domain_scores_codex":[0.9996735,0.0001763362,0.00003400192,0.00003798879,0.00004678133,0.00003138797],"domain_scores_gemma":[0.9993767,0.000114124,0.0001707122,0.00004339184,0.00006472453,0.0002304203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8183156,0.01493742,0.01146975,0.002228355,0.001521935,0.00009943159,0.0001295389,0.000413069,0.0330522,0.00009363753,0.005164493,0.1125746],"study_design_scores_gemma":[0.6126703,0.2972709,0.08002257,0.0002057562,0.001651249,0.0002273029,0.00005646895,0.0005458223,0.003614844,0.00008828568,0.003606129,0.00004049927],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825183,0.009267641,0.0004890088,0.00092929,0.0004319393,0.001549213,0.001362571,0.0002138759,0.003238218],"genre_scores_gemma":[0.9812379,0.004980295,0.001993276,0.001407968,0.0008915418,0.002341638,0.002730457,0.00002391417,0.004393082],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005631053,"threshold_uncertainty_score":0.01883775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06806692513860203,"score_gpt":0.3134014607066982,"score_spread":0.2453345355680962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}